Clinical Trials in Los Angeles

Showing 3021-3040 of 14,465 trials

Intermittent Theta Burst Stimulation for MDD

NCT02506127

This study will evaluate the effectiveness of intermittent Theta Burst Stimulation for patients with Major Depressive Disorder.

Major Depressive Disorder

University of California, Los Angeles30 participantsStarted Dec 2017

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

NCT00371033

The purpose of this study is to determine whether pregabalin is an effective treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)324 participantsStarted Mar 2006

Los Angeles, California, United States • Los Angeles, California, United States • Stanford, California, United States +8 more locations

Active Not RecruitingPhase 1< 1 mile

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

NCT04857372

The purpose of this study is to characterize the safety and tolerability of IAG933 in patients with mesothelioma, NF2/LATS1/LATS2 mutated tumors and tumors with functional YAP/TAZ fusions and to identify the maximum tolerated dose and/or recommended dose.

Mesothelioma

Novartis Pharmaceuticals137 participantsStarted Oct 2021

Los Angeles, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +13 more locations

Intermittent Theta Burst Stimulation for MDD

Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

Find Trials by Condition in Los Angeles

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

A Study of Auxora in Patients With Severe COVID-19 Pneumonia

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Clinical Procedures to Support Research in ALS

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects

HLA Demographics Study in Adults With Type 1 Diabetes

Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules

Short-course Regimens for the Treatment of Pulmonary Tuberculosis